首页 | 本学科首页   官方微博 | 高级检索  
检索        

经纤支镜灌注治疗耐多药肺结核
引用本文:吴福蓉,肖和平,唐神结.经纤支镜灌注治疗耐多药肺结核[J].临床肺科杂志,2002,7(1):14-15.
作者姓名:吴福蓉  肖和平  唐神结
作者单位:上海市肺科医院,200433
摘    要:目的 探讨经纤支镜灌注治疗耐多药肺结核的治疗价值。方法 将26例耐多药肺结核病患随机分为治疗组和对照组。治疗组强化期采用纤支镜灌注治疗加全身化疗,对照组只进行全身化疗。结果 强化期结束时,经纤支镜灌注治疗组症状明显改善92.86%,痰菌阴转率85.71%,病灶显吸收率78.58%,明显高于单纯化疗组58.33%、50%、33.33%(P<0.01-0.05)。结论 经纤支镜灌注治疗耐多药肺结核疗效显,且无并发症及明显副反应,值得进一步推广使用。

关 键 词:耐多药肺结核  纤支镜  MDR-PTB  化疗  药物灌注治疗  疗效

Bronchofiberscope in treatment of multi-drug resistant pulmonary tuberculosis
Wu Furong,Xiao Heping,Tang Shenjie.Bronchofiberscope in treatment of multi-drug resistant pulmonary tuberculosis[J].Journal of Clinical Pulmonary Medicine,2002,7(1):14-15.
Authors:Wu Furong  Xiao Heping  Tang Shenjie
Institution:Wu Furong,Xiao Heping,Tang Shenjie.Department of Tuberculosis Disease,Shanghai Pulmonology Hospital,Shanghai 200433
Abstract:Objective To evaluate the clinical value of bronchofiberscope in the treatment of multi drug resistant pulmonary tuberculosis.Method Patients with multi drug resistant pulmonary tuberculosis were randomly diveded into an experiment and a control group.The Experiment group was treated by bronchofiberscope and general antotuberculotic,and the control group only by general antituberculotic.Results After the therapy of initial phase,92.86% of patient in the experiment group had their symptoms greatly improved,the sputum conversion rates in the experimented group wew 85.71%.78.58% of patients had foci markedly absorbed,all of which were higher than the control group(58.33%,50% and 33.33% resoectively)(P<0.05).Conclusion The efficacy of fiber bronchoscope is better than the chemotherapy only in the treatment of multi drug resistant pulmonary tuberculosis.No complication and obvious adverse reaction were observed.
Keywords:Pulmonary tuberculosis  Multidrug  resistant therapy  Bronchofiberscope
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号